Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts 
Why the Middle East is being left behind by global climate finance plans 
China’s Growth Faces Structural Challenges Amid Doubts Over Data 
Investors Brace for Market Moves as Trump Begins Second Term 
Investors value green labels — but not always for the right reasons 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Today’s space race could turn fatal if we don’t agree on new rules 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
KiwiSaver shakeup: private asset investment has risks that could outweigh the rewards 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
